Outcomes of treatment of fungal keratitis at the university of iowa hospitals and clinics: A 10-year retrospective analysis

Cornea

Volumn 32, Issue 8, 2013, Pages 1131-1136

  Rogers, Gina M ^a   Goins, Kenneth M ^a   Sutphin, John E ^a,b   Kitzmann, Anna S ^a   Wagoner, Michael D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

fungal keratitis; optical keratoplasty; therapeutic keratoplasty

Indexed keywords

AMPHOTERICIN; IMIDAZOLE; POLYENE; STEROID; TRIAZOLE; VORICONAZOLE;

ADULT; AGED; ALTERNARIOSIS; ANTIBIOTIC THERAPY; ARTICLE; FEMALE; FUSARIOSIS; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; KERATOMYCOSIS; KERATOPLASTY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; COMBINED MODALITY THERAPY; CORNEAL TRANSPLANTATION; EYE INFECTIONS, FUNGAL; FEMALE; GRAFT SURVIVAL; HUMANS; IOWA; KERATITIS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; STEROIDS; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 84880571556     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182883e9d     Document Type: Article

References (49)

1. Forster RK, Rebell G. The diagnosis and management of keratomycoses. I. Cause and diagnosis. Arch Ophthalmol. 1975;93:975-978.
2. Tuli SS. Fungal keratitis. Clin Ophthalmol. 2011;5:275-279.
3. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetio-logical diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81:965-971.
4. Wong TY, Fong KS, Tan DT. Clinical and microbial spectrum of fungal keratitis in Singapore: a 5-year retrospective study. Int Ophthalmol. 1997;21:127-130.
5. Xie L, Zhong W, Shi W, et al. Spectrum of fungal keratitis in north China. Ophthalmology. 2006;113:1943-1948.
6. Gugnani HC, Talwar RS, Njoku-Obi ANU, et al. Mycotic keratitis in Nigeria. A study of 21 cases. Br J Ophthalmol. 1976;60:607-613.
7. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38-47.
8. Chin GN, Hyndiuk RA, Kwasny GP, et al. Keratomycosis in Wisconsin. Am J Ophthalmol. 1975;79:121-125.
9. Doughman DJ, Leavenworth NM, Campbell RC, et al. Fungal keratitis at the University of Minnesota: 1971-1981. Trans Am Ophthalmol Soc. 1982;80:235-247.
10. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19: 307-312.
11. Ritterband DC, Seedor JA, Shah MK, et al. Fungal keratitis at the New York Eye and Ear Infirmary. Cornea. 2006;25:264-267.
12. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994;101:1005-1013.
13. Jurkunas U, Behlau I, Colby K. Fungal keratitis: changing pathogens and risk factors. Cornea. 2009;28:638-643.
14. Gower EW, Keay LJ, Oechsler RA, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010;117:2263-2267.
15. Keay LJ, Gower EW, Iovieno A, et al. Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a mul-ticenter study. Ophthalmology. 2011;118:920-926.
16. Wong TY, Ng TP, Fong KS, et al. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997;23:275-281.
17. Alfonso E, Mandelbaum S, Fox MJ, et al. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol. 1986;101:429-433.
18. Wilhelmus KR, Robinson NM, Font RA, et al. Fungal keratitis in contact lens wearers. Am J Ophthalmol. 1988;106:708-714.
19. Chang DC, Grant GB, O'Donnell K, et al; the Fusarium Keratitis Investigation Team. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953-963.
20. Gorscak JJ, Ayres BD, Bhagat N, et al. An outbreak of Fusarium keratitis associated with contact lens use in the northeastern United States. Cornea. 2007;26:1187-1194.
21. Shukla PK, Kumar M, Keshava GB. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses. 2008;51:183-199.
22. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye center in South India. Cornea. 2002;21:555-559.
23. Jones BR. n;79:719-725.
24. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology. 1981;88:814-820.
25. O'Day DM, Head WS. Advances in the management of keratomycosis and Acanthamoeba keratitis. Cornea. 2000;19:681-687.
26. Wong TY, Ng TP, Fong KS, et al. Risk factors and clinical outcomes between fungal and bacterial keratitis: a comparative study. CLAO J. 1997;23:275-281.
27. Hyndiuk RA, Yee RW. Antifungal agents. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye. Boston, MA: Little Brown; 1986:239-256.
28. Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010;128:672-678.
29. Cuenca-Estrella M, Díaz-Guerra TM, Mellado E, et al. Comparative in vitro activity of voriconazole and itraconazole against fluconazole- susceptible and fluconazole-resistant clinical isolates of Candida species from Spain. Eur J Clin Microbiol Infect Dis. 1999;18:432-435.
30. Hoffman HL, Rathbun RC. Review of the safety and efficacy of vorico-nazole. Expert Opin Investig Drugs. 2002;11:409-429.
31. Arora R, Gupta D, Goyal J, et al. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers. Clin Experiment Ophthalmol. 2011;39:434-440.
32. Singh G, Malik SR. Therapeutic keratoplasty in fungal corneal ulcers. Br J Ophthalmol. 1972;56:41-45.
33. Forster RK, Rebell G. Therapeutic surgery in failures of medical treatment for fungal keratitis. Br J Ophthalmol. 1975;59:366-371.
34. Xie L, Shi W, Liu Z, et al. Lamellar keratoplasty for the treatment of fungal keratitis. Cornea. 2002;21:33-37.
35. Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol. 2001;85:1070-1074.
36. Yao YF, Zhang YM, Zhou P, et al. Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas. Br J Ophthalmol. 2003;87:543-547.
37. Chen WL, Wu CY, Hu FR, et al. Therapeutic penetrating keratoplasty for microbial keratitis in Taiwan from 1987 to 2001. Am J Ophthalmol. 2004;137:736-743.
38. Xie L, Zhai H, Shi W. Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea. 2007;26:158-162.
39. Belliappa S, Hade J, Kim S, et al. Surgical outcomes in cases of contact lens-related Fusarium keratitis. Eye Contact Lens. 2010;36:190-194.
40. Crisol SM, Alfonso EC, Guildford JH, et al. Results of large penetrating keratoplasty in microbial keratitis. Cornea. 1996;15:571-576.
41. Killingsworth DW, Stern GA, Dreibe WT, et al. Results of therapeutic keratoplasty. Ophthalmology. 1993;100:534-541.
42. Se Ti, Scott JA, Janardhanan P, et al. Therapeutic keratoplasty for advanced suppurative keratitis. Am J Ophthalmol. 2007;143:755-762.
43. Xie L, Zhai H, Shi W, et al. Hyphal growth patterns and recurrence of fungal keratitis after lamellar keratoplasty. Ophthalmology. 2008;115: 983-987.
44. Xie L, Hu J, Shi W. Treatment failure after lamellar keratoplasty for fungal keratitis. Ophthalmology. 2008;115:33-36.
45. Jangi AA, Ritterband DC, Wu EI, et al. Descemet stripping automated endothelial keratoplasty after failed penetrating keratoplasty. Cornea. 2012;31:1148-1153.
46. Clements JL, Bouchard CS, Lee WB, et al. Retrospective review of graft dislocation rate associated with descemet stripping automated endothelial keratoplasty after primary failed penetrating keratoplasty. Cornea. 2011; 30:414-418.
47. Kitzmann AS, Wandling GR, Sutphin JE, et al. Comparison of penetrating keratoplasty versus Descemet's stripping automated endothelial keratoplasty for penetrating keratoplasty graft failure due to corneal edema. Int Ophthalmol. 2012;32:15-23.
48. Zerbe BL, Belin MW, Ciolino JB; Boston Type 1 Keratoprosthesis Study Group. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:1779.e1-1779.e7.
49. Chen JJ, Cohen AW, Wagoner MD, et al. The "silent brain syndrome" creating a severe form of the "giant fornix syndrome." Cornea. 2012;31: 1065-1067.